The meta-analysis of Fluoxetine treatment efficacy in adult MDD patients also revealed that its effectiveness of Fluoxetine was associated with the levels of IL-6 and IL-1β in the peripheral blood (19). The gene discussed is IL6; the disease is major depressive disorder.